Diagnostics For The Real Worlddrwis A Uk Based Molecular Diagnostics Company Established In 2003Originating From The University Of Cambridgeae S Diagnostics Development Unitthe Company Specializes In Developing Rapiddecentralized Point Of Care Diagnostic Solutions For Infectious Diseasesparticularly In Resource Limited Settingswhile Also Expanding Into Developed Markets Drw S Flagship Product Is The Samba Platforma Robust Molecular Diagnostic System That Operates Effectively In Various Conditions Without The Need For Cold Chain Logisticsthe Latest Versionsamba Iisupports Multiplex Testing For Respiratory Virusesincluding Covid 19 And Influenzathe Company Is Also Set To Launch Six New Test Panels In 2025Further Enhancing Its Infectious Disease Offeringsdrw Has Established A Strong Presence In Both Resource Limited Areasparticularly In Africaand Developed Marketssecuring Contracts For Its Sars Cov 2 Test In The Uk And Gaining Approvals For Multiplex Tests In New Zealand
